Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Jazz Pharma Plc (JAZZ)

Jazz Pharma Plc (JAZZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,641,982
  • Shares Outstanding, K 62,966
  • Annual Sales, $ 3,094 M
  • Annual Income, $ -329,670 K
  • 60-Month Beta 0.71
  • Price/Sales 2.69
  • Price/Cash Flow 6.78
  • Price/Book 3.54
Trade JAZZ with:

Options Overview Details

View History
  • Implied Volatility 29.73% ( +1.06%)
  • Historical Volatility 21.41%
  • IV Percentile 20%
  • IV Rank 14.53%
  • IV High 52.79% on 11/16/22
  • IV Low 25.81% on 08/15/22
  • Put/Call Vol Ratio 0.75
  • Today's Volume 121
  • Volume Avg (30-Day) 183
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 2,848
  • Open Int (30-Day) 8,338

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 3.84
  • Number of Estimates 5
  • High Estimate 4.58
  • Low Estimate 3.34
  • Prior Year 3.66
  • Growth Rate Est. (year over year) +4.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
150.80 +1.55%
on 01/10/23
158.93 -3.65%
on 01/13/23
-5.66 (-3.56%)
since 01/06/23
3-Month
139.36 +9.88%
on 11/09/22
160.96 -4.86%
on 01/03/23
+6.70 (+4.58%)
since 11/04/22
52-Week
125.36 +22.15%
on 09/27/22
169.98 -9.91%
on 04/07/22
+12.19 (+8.65%)
since 02/04/22

Most Recent Stories

More News
3 Biotech Stocks to Get in on Before It’s Too Late

Rapidly growing market for personalized medicines and revolutionary technologies like 3D bioprinting is expected to bolster the biotech industry. Moreover, rising government initiatives should support...

BIIB : 288.28 (+1.64%)
JAZZ : 153.13 (-1.61%)
VRTX : 304.87 (+1.28%)
3 Cannabis Stocks With Double-Digit Percentage Revenue Growth

Cannabis stocks had a rough time over the past year, with the EFT Alternative Harvest ETF (NYSEMKT: MJ) and the AdvisorShares Pure Cannabis ETF (NYSEMKT: YOLO) down by more than 53% and 64%, respectively....

MJ : 4.59 (-0.65%)
YOLO : 3.76 (-0.27%)
AAWH : 1.4100 (+2.55%)
JAZZ : 153.13 (-1.61%)
GTBIF : 8.6885 (+1.74%)
The Ultimate Growth Stocks to Buy With $300 Right Now

These three companies should deliver inflation-busting long-term growth.

MDT : 85.24 (-2.14%)
JAZZ : 153.13 (-1.61%)
INSP : 243.99 (-2.93%)
AXSM : 65.45 (-4.73%)
ALB : 276.81 (-3.63%)
Strength Seen in Catalyst (CPRX): Can Its 9.2% Jump Turn into More Strength?

Catalyst (CPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

CPRX : 15.87 (-1.43%)
JAZZ : 153.13 (-1.61%)
2 Promising New Growth Stocks to Watch in 2023

These stocks have plenty of room to run.

JAZZ : 153.13 (-1.61%)
INMD : 36.46 (-2.09%)
AXSM : 65.45 (-4.73%)
Jazz (JAZZ) Gastric Cancer Study Shows Improved Overall Survival

Jazz (JAZZ) reports data from a mid-stage study on its investigational bispecific antibody targeting HER2-expressing mGEA. The treatment achieved an overall survival rate of 84% in 18 months.

JAZZ : 153.13 (-1.61%)
BGNE : 245.18 (-4.56%)
ZYME : 9.82 (+3.59%)
ALLO : 7.67 (-1.41%)
Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evaluating Zanidatamab in HER2-Expressing Metastatic Gastroesophageal Adenocarcinoma

Results presented today at ASCO GI include first overall survival (OS) data for zanidatamab, overall confirmed objective response rate (cORR) of 79%, disease...

JAZZ : 153.13 (-1.61%)
ZYME : 9.82 (+3.59%)
3 Biotech Stocks to Help Boost Your Portfolio in January

Increased government initiatives and the rising adoption of biotechnology in healthcare and agriculture are likely to enhance the growth of the biotech industry. Hence, fundamentally sound biotech stocks...

BIIB : 288.28 (+1.64%)
JAZZ : 153.13 (-1.61%)
VRTX : 304.87 (+1.28%)
2 Stocks That Beat the Market in 2022 and That Analysts Think Can Go Higher

There are still plenty of growth opportunities left for these businesses.

JAZZ : 153.13 (-1.61%)
TMUS : 141.97 (-2.22%)
These Stocks Jumped 100% and 30% Last Year. Here's Why They're Still a Buy.

These stocks look cheap if you take a long-term view.

JAZZ : 153.13 (-1.61%)
AXSM : 65.45 (-4.73%)
VRTX : 304.87 (+1.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients....

See More

Key Turning Points

3rd Resistance Point 162.23
2nd Resistance Point 159.62
1st Resistance Point 156.37
Last Price 153.13
1st Support Level 150.51
2nd Support Level 147.90
3rd Support Level 144.65

See More

52-Week High 169.98
Last Price 153.13
Fibonacci 61.8% 152.94
Fibonacci 50% 147.67
Fibonacci 38.2% 142.40
52-Week Low 125.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar